(IN BRIEF) QIAGEN has filed a lawsuit against bioMérieux in the German Unified Patent Court to protect its QuantiFERON technology, specifically its European Patent EP 2 276 883 B2, which covers innovations in QuantiFERON-TB Gold Plus used for TB detection. … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Law, Management, Netherlands, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged bioMérieux, CDC, Düsseldorf, European Patent EP 2 276 883 B2, infectious disease diagnostics, intellectual property, latent tuberculosis, Molecular Diagnostics, patent lawsuit, public health, QIAGEN, QuantiFERON technology, QuantiFERON-TB Gold Plus, SD Biosensor, TB detection, Thierry Bernard, tuberculosis, tuberculosis control, Unified Patent Court, WHO
(IN BRIEF) Roche has received CE certification for its enhanced cobas® 6800/8800 systems 2.0, introducing significant improvements in laboratory diagnostics. The upgrade streamlines operations by reducing downtime, consolidating test menus, and increasing throughput, supported by innovative TAGS technology that detects … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged cobas Systems 2.0, Matt Sause, Molecular Diagnostics, Roche, safety
(IN BRIEF) Bosch and Randox Laboratories Ltd. have forged a strategic partnership aimed at transforming molecular diagnostics with a focus on the Vivalytic analysis platform. With an investment of 150 million euros in joint research, development, and distribution, the collaboration … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Ireland, Management, News, Pharma & Biotech, Science, Technology
Tagged Bosch, Dr. Peter Fitzgerald, Healthcare, Marc Meier, Molecular Diagnostics, partnership, Randox Labs, Stefan Hartung
New real-time PCR rapid test for detection of four STI First Vivalytic test in cooperation with development partner BioGX Positive test results available within an hour directly at the point of care (PRESS RELEASE) WAIBLINGEN, Germany, 9-Jun-2022 — /EuropaWire/ — … Read the full press release
Posted in Germany, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged BioGX, Bosch Healthcare Solutions, CE-label, infectious urethritis, M&G, MH, Molecular Diagnostics, Mycoplasma genitalium, Mycoplasma hominis, pathogens, PCR rapid test, sexually transmitted infections, STI differential diagnosis, STIs, UP, Ureaplasma parvum, Ureaplasma urealyticum, UU, Vivalytic, Vivalytic analyser
Nouveau test rapide PCR en temps réel pour la détection de quatre IST Premier test Vivalytic en coopération avec le partenaire de développement BioGX Résultats de test positifs disponibles dans l’heure directement au point de service (COMMUNIQUÉ DE PRESSE) WAIBLINGEN, … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech, Science, Technology
Tagged agents pathogènes, analyseur Vivalytic, BioGX, Bosch Healthcare Solutions, CE-label, diagnostic moléculaire, infections sexuellement transmissibles, infectious urethritis, IST, marquage CE, MG, MH, Molecular Diagnostics, Mycoplasma genitalium, Mycoplasma hominis, pathogens, PCR rapid test, sexually transmitted infections, STI diagnostic différentiel, STI differential diagnosis, STIs, test rapide PCR, UP, Ureaplasma parvum, Ureaplasma urealyticum, urétrite infectieuse, UU, Vivalytic, Vivalytic analyser
(PRESS RELEASE) VENLO, the Netherlands, 8-Jan-2021 — /EuropaWire/ — QIAGEN announces the appointment of Dr. Toralf Haag as a member of the Supervisory Board with immediate effect. He will also become a member of the Audit Committee. Dr. Haag was … Read the full press release
Posted in Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged appointment, Assay technologies, Audit Committee, Bioinformatics, biomolecules, diagnostics, DNA, Dr. Toralf Haag, Lawrence Rosen, life sciences, Lonza Group AG, Molecular Diagnostics, QIAGEN, RNA, Sample to Insight, Supervisory Board, Thyssen Handelsunion AG, University of Augsburg, University of Kiel, Voith GmbH & Co. KGaA
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?